Cytosurge AG is an ETH Zurich spin-off Company based in Zurich, Switzerland. The vision of Cytosurge is to provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, life sciences and single cell biology.
The company develops the patented FluidFM technology and is present in all major markets throughout Europe, Asia and the Americas. Cytosurge AG is a passionate team of specialists with backgrounds in various disciplines from business, engineering, biology and computer science
The Cytosurge flagship product provides the most comprehensive FluidFM experience. Go beyond imaging with the FluidFM BOT.
With the FluidFM BOT, you can benefit from extended automation and a revolutionary sample positioning system. The FluidFM BOT supports the complete range of FluidFM...
